The Role of Biomarkers and Genetic Predisposition in Treatment Selection The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
Whenever we give medication to a large portion of the population without long-term safety, one is concerned about what those long-term safety signals are going to be. COPD exacerbations carry significant morbidity and significant cost of the healthcare system, and so I would like to see data to prevent, to figure out how we can minimize the incidence of COPD as a new patient developing COPD, he added
Conversely, GLP-1 RAs demonstrated no significant benefits in improving neurocognition or psychosocial functioning in schizophrenia, cocaine addiction, or dementia
A small subset of the population has a condition called G6PD deficiency
Limitations about to be overcome
Comparison of glycemic control and -cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment
